BioNTech SE on X: “Small cell lung cancer is a key focus at #BioNTech with multiple trial…”

A fast, private reader for public X posts. No account, no tracking, no pop-ups.

PeekX is an independent tool and is not affiliated with, endorsed by or sponsored by X Corp. “X” and “Twitter” are trademarks of their respective owners. We only show posts that their authors made public and never access private or protected accounts. Downloaded media belongs to its creators — please respect their rights.

Username or post link

Home / @BioNTech_Group / Post

BioNTech SE

@BioNTech_Group

Small cell lung cancer is a key focus at #BioNTech with multiple trials across disease stages. At #WCLC25, we share global interim Phase 2 data on our PD-L1xVEGF-A bispecific antibody candidate in extensive-stage small cell lung cancer.